Family planning a powerful tool for reducing maternal death
Tuesday, November 5, 2013
: 10:45 a.m. - 11:00 a.m.
Over the last 8 years, the Ministry of Health, the National Public Health Directorate (NPHD), along with international and national organizations increased family planning (FP) use from 6% to 17.7%. These efforts must be strengthened to continue reductions in maternal death and reach the Millennium Development Goals. FP is a powerful tool to achieve this objective. In Angola in 2010, 879 maternal deaths were averted due to contraceptive use, representing 15.5% of maternal deaths.In 2010, the NPHD piloted introduction of the Jadelle implant in 2 hospitals over a 9 month period. During this time, 709 implants were inserted. Since 2012, SASH, financed by USAID/ Angola, has supported the introduction of Jadelle to health centers in Luanda and Huambo. The introduction includes 4 elements: personalized counseling, hands-on practice during training with anatomic models and later with patients, focused technical assistance to establish the new service in the facility and radio messaging. From April 2012, 23 new services were established in the two provinces of Huambo and Luanda and as a result 6,424 implants were inserted. This demonstrates the need of Angolan women to use an effective FP method, and that changes in the model of care are required in order to make services more client-friendly.
Provision of health care to the public
Describe four elements of the approach used to introduce Jadelle in Angolan health facilities.
Discuss how many women were reached using Jadelle after this method was introduced in Angola.
Keyword(s): Family Planning, International Family Planning
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: As the head of Public Health Directorate at the MOH, the need to increase FP coverage to reduce maternal mortality has been an objective of the country's health strategy.Among my scientific interests is to see how FP can have a positive effect on reducing maternal mortality and receive imputs on the issue.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.